Cyndi Jenkins

Understanding and developing options for Canada's response and proposed policies related to tariffs Promote policies that increase access to telehealth solutions, including primary care and mental health through both private and public administration. Prescription drug policy and funding, with respect to access to high-cost drugs for rare diseases, the establishment of a national drug formulary, bulk purchasing programs Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals Federal human resources health and wellness policy and the promotion of mental health and digital health services Federal funding, as well as the development and testing of national standards, for mental health services to Canadians Development and implementation of a federally-funded dental care program for low-income Canadians Co-development of mental health programming for Indigenous populations Application of Harmonized Sales Tax (HST) to the activities of insurance intermediaries, as well as related enforcement and audit policies. Application by Green Shield Holdings Inc. to establish an insurance company

Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19. Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution. Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries. Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.

Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines o Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution. Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries. Federal Government First Nations and Inuit Health Branch program with respect to health services.

Offer recommendations on the Patented Medicines Pricing Review Board excessive pricing policy guidelines and implementation approaches to support drug supply stability and system sustainability Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs Medical cannabis policy impacts on pharmacy and the wholesale industry Health Canada, with respect to the role of wholesalers in the management of drug shortages Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities Health Canada, with respect to pandemic planning, particularly federal/provincial/territorial storage and distribution of pharmaceuticals Development of screening programs in First Nations communities Approaches towards National Pharmacare policy Approaches to mitigating the impact of COVID-19 on the pharmaceutical distribution, pharmacy, primary care, and other healthcare sectors

Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain. Drug pricing and pharmacare with regard to the pharmaceutical wholesale distribution chain.

Investigating opportunities for funding to establish processing facilities Engagement on proposed front of package labelling requirements

Seeking Government contract to provide aerial surveillance and logistics service for Canada’s North.

Trade and export controls and regulations related to the issuance or issuing of permits and certificates for various products included on Canada's Export Control List. Canada’s Defence Industrial Strategy - advocacy for policies and reforms to institutional practices that will support the Government's enunciated "Build–Partner–Buy" strategic framework to the benefit of Canadian service providers including PAL Aerospace. Canada's Northern Defence Policy, including objectives described in the 2024 Defence Policy Update "Our North Strong and Free" and related to Northern Operational Support Hubs, NORAD capabilities, and increasing the Canadian Armed Forces presence and responsiveness in the North in deterrence, detection and emergency response. Procurement in Canada, including the Directive on the Management of Procurement, international trade agreements, the financial administration act and the Code of Conduct for Procurement. Airline and Transportation Policy in Canada, with respect airline operations, safety management systems, competition, and service to regional, rural, remote and northern communities

Measures and policies related to increasing and enhancing the wages and retirement security support for SEIU members, especially Personal Support Workers. Ensuring the Safe Long Term Care Act, which has yet to be introduced, reflects support for the health, safety and working conditions of front line health care workers.

Infrastructure - Expand opportunities for long-term investors to support infrastructure investment, including opportunities to support investment in housing. Pensions & savings plans – Engage with public office holders regarding enhancing retirement and savings security for Canadians through retirement planning, public and registered savings plans, annuities, etc. Prescription drugs - Seeking to raise awareness about prescription drug & workplace benefit coverage. Group benefits & paramedical health care – Engage with public office holders regarding health care programs and policy that may impact group benefit plans. Climate/Environment – Engagements related to the impacts of extreme weather on the health and wellness of Canadians and expanding opportunities to meet our decarbonization commitments. International relations & trade – Engage with public office holders regarding international relations as it relates to Canada’s insurance industry. This includes how best to maximize the benefits of Canada’s trade relations for the industry and broader economy. Insurance and health regulation and legislation - Engage with public office holders regarding Canada’s financial services and health care sectors, in relation to the insurance industry. This may include the industry’s governing legislation and regulations, taxation policy, administration, and related issues, guidelines & rules. Cyber security, data, and privacy – Engage with public office holders on how to ensure the safety and integrity of Canada’s insurance industry’s data and technology systems. This may include engagement on privacy legislation, policy, and technological innovation in the insurance industry.

AMD Medicom was asked to apply for Strategic Innovation Fund funding from the Canadian Government to set up a manufacturing site in Canada. AMD Medicom is seeking to enter into a long-term contract to manufacture and supply nitrile gloves.

ATMIS as an Indigenous-owned manufacturing company that services clients across a variety of sectors, seeks funding from the Government of Canada to allow them to further develop and commercialize their manufacturing systems and solutions. ATMIS is a vertically integrated supplier of automated systems, custom tooling, and general machining. The company seeks a contract to provide its unique medical isolation gown manufacturing solution to the Federal Government.

Supporting Abbott executives to engage officials in relation to matters concerning healthcare and nutrition.